@article{621c24af5501435e94e5d78a873f9769,
title = "Low relapse rate leads to high concordance of sustained virologic response (SVR) at 12 weeks with SVR at 24 weeks after treatment with ABT-450/ritonavir, ombitasvir, and dasabuvir plus ribavirin in subjects with chronic hepatitis c virus genotype 1 infection in the AVIATOR study",
abstract = "In 247 subjects with hepatitis C virus genotype 1 infection treated with the interferon-free regimen of ABT-450/ritonavir, ombitasvir, and dasabuvir plus ribavirin, concordance of a sustained virologic response at 12 and 24 weeks supports the use of the earlier time point as a primary efficacy endpoint for trials of this interferon-free regimen.",
keywords = "concordance, direct-acting antivirals, hepatitis C, sustained virologic response",
author = "Fred Poordad and Kosh Agarwal and Ziad Younes and Daniel Cohen and Wangang Xie and Thomas Podsadecki",
note = "Publisher Copyright: {\textcopyright} The Author 2014.",
year = "2015",
month = feb,
day = "15",
doi = "10.1093/cid/ciu865",
language = "English (US)",
volume = "60",
pages = "608--610",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "4",
}